Acromegaly Update podcast

Acromegaly Update — Monday November 16, 2026

0:00
7:00
Rewind 15 seconds
Fast Forward 15 seconds
Another incremental week for acromegaly research, led by evidence that upper-limb joint damage is nearly universal in patients and an early AI voice test for diagnosis, while rare disease industry news was dominated by deal-making (Lilly's up-to-$1.5B Calytrix buyout, argenx's Unnatural Products acquisition), a positive pivotal hepatitis delta readout from Vir, and Novo's sickle cell filing.

More episodes from "Acromegaly Update"